0001157523-21-001284.txt : 20211028 0001157523-21-001284.hdr.sgml : 20211028 20211028172709 ACCESSION NUMBER: 0001157523-21-001284 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20211028 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20211028 DATE AS OF CHANGE: 20211028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APTARGROUP INC CENTRAL INDEX KEY: 0000896622 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS PRODUCTS, NEC [3089] IRS NUMBER: 363853103 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11846 FILM NUMBER: 211359603 BUSINESS ADDRESS: STREET 1: 475 W TERRA COTTA AVE STREET 2: STE E CITY: CRYSTAL LAKE STATE: IL ZIP: 60014 BUSINESS PHONE: 8154770424 MAIL ADDRESS: STREET 1: 475 W. TERRA COTTA AVE. SUITE E CITY: CRYSTAL LAKE STATE: IL ZIP: 60014 8-K 1 a52517971.htm APTARGROUP INC 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


October 28, 2021
Date of Report (Date of earliest event reported)

AptarGroup, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
001-11846
36-3853103
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
     
265 Exchange Drive, Suite 100, Crystal Lake, Illinois 60014
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: 815-477-0424.
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, $.01 par value
 
ATR
 
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company    ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ⃞


Item 2.02   Results of Operations and Financial Condition.
 
On October 28, 2021, AptarGroup, Inc. announced certain information related to its results of operations for the quarter and nine months ended September 30, 2021. The press release regarding this announcement is furnished as Exhibit 99.1 hereto.
 
The information in Item 2.02 of this Form 8-K and the Exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01   Financial Statements and Exhibits.

 
(d) Exhibits
 
 
 
 
 
 
104            Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 
 

SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

   
AptarGroup, Inc.
  
       
       
Date:  October 28, 2021
By:
/s/ Robert W. Kuhn  
    Robert W. Kuhn
  
    Executive Vice President and
  
    Chief Financial Officer
  

EX-99.1 2 a52517971ex99_1.htm EXHIBIT 99.1
 
 Exhibit 99.1


Aptar Reports Third Quarter 2021 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--October 28, 2021--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported third quarter results for 2021.

Third Quarter 2021 Summary

  • Reported sales grew 9%, primarily driven by double-digit core sales growth in Beauty + Home and Food + Beverage from a combination of price increases and volume growth
  • Core sales (excluding currency effects) increased 8%
  • Pharma sales declined slightly compared to the prior year
  • Reported earnings per share totaled $0.70 and included restructuring charges ($0.12), an unrealized loss on an equity investment ($0.10) resulting from the mark-to-market position of our investment in PureCycle Technologies, Inc. (purification recycling technology) and acquisition costs ($0.02)
  • Adjusted earnings per share, excluding restructuring charges, the loss on the equity investment and acquisition costs, totaled $0.94
  • Reported net income totaled $47 million
  • Adjusted EBITDA totaled $154 million
  • Acquisition Updates:
    • Completed the acquisition of 80% of Weihai Hengyu Medical Products, adding elastomeric and plastic component manufacturing capabilities in China for injectable drug delivery
    • Completed the acquisition of a majority stake in Voluntis, a provider of digital therapeutic solutions

Third Quarter Results

For the quarter ended September 30, 2021, reported sales increased 9% to $825 million compared to $759 million in the prior year. Core sales, excluding the impact from changes in currency exchange rates, increased 8%.

Third Quarter Segment Sales Analysis
(Change Over Prior Year)




 

Pharma Beauty + Home Food + Beverage Total AptarGroup
Core Sales Growth

(2

%)

10

%

28

%

8

%

Acquisitions

0

%

0

%

0

%

0

%

Currency Effects (1)

1

%

1

%

2

%

1

%

Total Reported Sales Growth

(1

%)

11

%

30

%

9

%









 
(1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.

Stephan B. Tanda, President and CEO, said, “Growth during the quarter continued to be driven by our Beauty + Home and Food + Beverage segments as our beauty business continued to recover and our food business benefited from continued cooking at home trends. Our Pharma segment benefited from growth in demand for components for injected medicines and consumer health care solutions, but this was offset by lower demand for prescription allergy and asthma devices, and lower active material custom tooling sales compared to the prior year.”

In the Pharma segment, the increase in the number of COVID-19 cases during the year prolonged the drawing down of inventories by customers in sectors such as allergic rhinitis, cough and cold and certain pulmonary categories. This resulted in a decline in sales to the prescription drug market which reduced the Pharma segment’s profit margin compared to the prior year.

The Beauty + Home segment generated strong sales growth on a rebound in demand in the beauty market and price adjustments. Demand for personal care product solutions was mixed, with increases in demand for hair care and body care dispensing systems and lower demand for personal cleansing and sanitizer dispensing systems.

The Food + Beverage segment reported double-digit core sales growth. This was primarily driven by price adjustments and increased demand for food dispensing closures for sauces and condiments, as consumers continued to cook at home, and we saw a partial recovery of sales of closures for bottled water and on-the-go functional drinks. Beauty + Home and Food + Beverage margins were impacted by rising input costs compared to the prior year.

Aptar reported third quarter earnings per share of $0.70 compared to $0.95 during the same period a year ago. Third quarter adjusted earnings per share, excluding restructuring charges, acquisitions costs and the unrealized loss on an equity investment, were $0.94 compared to $1.01 in the prior year, including comparable exchange rates.

Year-to-Date Results

For the nine months ended September 30, 2021, reported sales increased 11% to $2.41 billion compared to $2.18 billion in the prior year. Core sales, excluding the impacts from changes in currency exchange rates and acquisitions, increased 6%.

Nine Months Year-to-Date Segment Sales Analysis
(Change Over Prior Year)
 

Pharma Beauty + Home Food + Beverage Total AptarGroup
Core Sales Growth

0

%

6

%

22

%

6

%

Acquisitions

0

%

2

%

0

%

1

%

Currency Effects (1)

4

%

4

%

3

%

4

%

Total Reported Sales Growth

4

%

12

%

25

%

11

%

 
(1) - Currency effects are approximated by translating last year's amounts at this year's foreign exchange rates.

Tanda commented on the year-to-date results, “Broad-based demand for our innovative solutions drove core sales growth in each of our end markets, with the exception of the prescription drug market, which has been impacted by lower demand for devices for allergy and asthma treatments given the late summer resurgence of COVID-19 because of the Delta variant. Price adjustments to offset increased input costs and positive currency effects also contributed to strong top line growth of 11%. Core sales increased 6% driven by growth in our Beauty + Home and Food + Beverage segments. I am very proud of our global workforce and their resiliency in delivering on our promises to our customers across the many markets we serve, despite the variability and uncertainty of demand and more recently, rising inflation and supply chain challenges.”

For the nine months year-to-date, Aptar’s reported earnings per share were $2.75, an increase of 14%, compared to $2.42 reported a year ago. Current year adjusted earnings per share, excluding restructuring charges, acquisitions costs and the net gain on an equity investment, were $2.94 and increased 4% from prior year adjusted earnings per share, including comparable exchange rates, of $2.84. Free cash flow for the first nine months was impacted by higher capital expenditures and changes in working capital.

Outlook

For the fourth quarter, core sales growth is expected in each business segment. Earnings growth is expected to be tempered due to the business mix in the Pharma segment, sequential foreign currency translation headwinds, rising inflation and supply chain disruptions including labor shortages.

Tanda stated, “Inflation continues to escalate, and the pace of recovery is more uneven than previously expected due to the surge of the COVID-19 Delta variant during the summer months and supply chain disruptions. However, we anticipate further, gradual progress in the beauty market and continued good sales momentum in elastomer components and active material solutions. Last year we posted a particularly strong fourth quarter for prescription drug delivery devices and food and beverage closures, so we will have more difficult comparisons for those markets.”

Aptar expects earnings per share for the fourth quarter of 2021, excluding any restructuring expenses, acquisition costs and changes in the fair value of equity investments, to be in the range of $0.88 to $0.96 and this guidance is based on an effective tax rate range of 28% to 30%.

Tanda continued, “As we navigate the current environment, we remain focused on cost containment and we are continuing to increase prices to offset rising input costs. Our global procurement team is doing a tremendous job of navigating the tenuous energy markets and supply chains to secure the necessary materials, supplies and equipment we need. At the same time, I’m confident the completion of our recent acquisitions and the growth investments we are making such as increasing our capacity to produce elastomer components for injected medicines and active material science solutions, will support our future growth and drive continued value creation.”

Capital Allocation

As previously announced, Aptar’s Board of Directors declared a quarterly cash dividend of $0.38 per share. The payment date is November 17, 2021, to stockholders of record as of October 27, 2021.

During the three and nine months ended September 30, 2021, the Company repurchased approximately 220,000 shares of common stock for $28.4 million, leaving $250 million authorized for common stock repurchases at the end of the third quarter. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions.

Open Conference Call

There will be a conference call held on Friday, October 29, 2021 at 8:00 a.m. Central Time to discuss the Company’s third quarter results for 2021. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investor Relations page of the website.

About Aptar

Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.

Presentation of Non-GAAP Information

This press release refers to certain non-GAAP financial measures, including current year adjusted earnings per share and adjusted EBITDA, which exclude the impact of business transformation charges (restructuring initiatives), acquisition-related costs, certain purchase accounting adjustments related to acquisitions and investments and net investment gains and losses related to observable market price changes on equity securities. Core sales and adjusted earnings per share also neutralize the impact of foreign currency translation effects when comparing current results to the prior year. Non-GAAP financial measures may not be comparable to similarly titled non-GAAP financial measures provided by other companies. Aptar’s management believes these non-GAAP financial measures provide useful information to our investors because they allow for a better period over period comparison of operating results by removing the impact of items that, in management’s view, do not reflect Aptar’s core operating performance. These non-GAAP financial measures also provide investors with certain information used by Aptar’s management when making financial and operational decisions. Free cash flow is calculated as cash provided by operating activities less capital expenditures. We use free cash flow to measure cash flow generated by operations that is available for dividends, share repurchases, acquisitions and debt repayment. We believe that it is meaningful to investors in evaluating our financial performance and measuring our ability to generate cash internally to fund our initiatives. These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial results but should be read in conjunction with the unaudited condensed consolidated statements of income and other information presented herein. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures is included in the accompanying tables. Our outlook is provided on a non-GAAP basis because certain reconciling items are dependent on future events that either cannot be controlled, such as exchange rates and changes in the fair value of equity investments, or reliably predicted because they are not part of the Company's routine activities, such as restructuring and acquisition costs.

This press release contains forward-looking statements, including certain statements set forth under the “Outlook” section of this press release. Words such as “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential” and other similar expressions or future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results or other events may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: pandemics, including the impact of the COVID-19 pandemic on our global supply chain and our global customers and operations; our ability to preserve organizational culture and maintain employee productivity in the work-from-home environment caused by the current pandemic; the successful integration of acquisitions and the achievement of the expected benefits of acquisitions and investments; our ability to build out acquired business and integrate the product/service offering of the acquired entities into our existing product/service portfolio; the impact of tax reform legislation including changes in tax rates and other tax-related events or transactions that could impact our effective tax rate; economic conditions worldwide including inflationary (and potential deflationary) conditions or economic downturn or uncertainty in regions we rely on for growth as a result of the COVID-19 pandemic or otherwise; fluctuations in the cost of materials, components, transportation cost as a result of supply chain disruptions and labor shortages, and other input costs (particularly resin, metal, anodization costs, and energy costs); political conditions worldwide; significant fluctuations in foreign currency exchange rates; changes in customer and/or consumer spending levels; financial conditions of customers and suppliers; consolidations within our customer or supplier bases; the availability of direct labor workers and the increase in direct labor costs; our ability to successfully implement facility expansions and new facility projects; our ability to increase prices, contain costs and improve productivity; changes in capital availability or cost, including interest rate fluctuations; volatility of global credit markets; cybersecurity threats that could impact our networks and reporting systems; fiscal and monetary policies and other regulations; direct or indirect consequences of acts of war or terrorism; and work stoppages due to labor disputes. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Form 10-K and Form 10-Qs. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

AptarGroup, Inc.
Condensed Consolidated Financial Statements (Unaudited)
(In Thousands, Except Per Share Data)
Consolidated Statements of Income







 

Three Months Ended


Nine Months Ended


September 30,


September 30,


2021


2020


2021


2020








 
Net Sales

$

825,442

 


$

759,153

 


$

2,413,228

 


$

2,180,011

 

Cost of Sales (exclusive of depreciation and amortization shown below)

 

537,085

 


 

479,672

 


 

1,548,840

 


 

1,372,630

 

Selling, Research & Development and Administrative

 

135,931

 


 

121,850

 


 

411,192

 


 

371,407

 

Depreciation and Amortization

 

59,280

 


 

55,179

 


 

174,508

 


 

162,414

 

Restructuring Initiatives

 

10,223

 


 

3,415

 


 

18,771

 


 

15,585

 

Operating Income

 

82,923

 


 

99,037

 


 

259,917

 


 

257,975

 

Other Income (Expense):






Interest Expense

 

(8,011

)


 

(8,851

)


 

(22,601

)


 

(25,973

)

Interest Income

 

401

 


 

249

 


 

1,406

 


 

599

 

Net Investment (Loss) Gain

 

(9,021

)


 

-

 


 

6,177

 


 

-

 

Equity in Results of Affiliates

 

(71

)


 

(256

)


 

(505

)


 

(1,383

)

Miscellaneous, net

 

13

 


 

(1,040

)


 

(2,978

)


 

(3,375

)

Income before Income Taxes

 

66,234

 


 

89,139

 


 

241,416

 


 

227,843

 

Provision for Income Taxes

 

19,340

 


 

25,404

 


 

55,309

 


 

66,998

 

Net Income

$

46,894

 


$

63,735

 


$

186,107

 


$

160,845

 

Net Loss (Income) Attributable to Noncontrolling Interests

 

366

 


 

(19

)


 

381

 


 

(37

)

Net Income Attributable to AptarGroup, Inc.

$

47,260

 


$

63,716

 


$

186,488

 


$

160,808

 

Net Income Attributable to AptarGroup, Inc. per Common Share:






Basic

$

0.72

 


$

0.99

 


$

2.84

 


$

2.50

 

Diluted

$

0.70

 


$

0.95

 


$

2.75

 


$

2.42

 








 
Average Numbers of Shares Outstanding:






Basic

 

65,900

 


 

64,562

 


 

65,652

 


 

64,278

 

Diluted

 

67,801

 


 

66,922

 


 

67,799

 


 

66,483

 

AptarGroup, Inc.
Condensed Consolidated Financial Statements (Unaudited)
(continued)
($ In Thousands)
Consolidated Balance Sheets



 

September 30, 2021
December 31, 2020
ASSETS





 
Cash and Equivalents

$

114,557


$

300,137

Short-term Investments

 

319


 

243

Total Cash and Equivalents, and Short-term Investments

 

114,876


 

300,380

Accounts and Notes Receivable, Net

 

662,112


 

566,623

Inventories

 

437,343


 

379,379

Prepaid and Other Current Assets

 

129,728


 

122,613

Total Current Assets

 

1,344,059


 

1,368,995

Property, Plant and Equipment, Net

 

1,248,964


 

1,198,748

Goodwill

 

986,779


 

898,521

Other Assets

 

551,683


 

523,789

Total Assets

$

4,131,485


$

3,990,053




 
LIABILITIES AND EQUITY





 
Short-Term Obligations

$

201,257


$

117,866

Accounts Payable, Accrued and Other Liabilities

 

707,111


 

662,463

Total Current Liabilities

 

908,368


 

780,329

Long-Term Obligations

 

915,750


 

1,054,998

Deferred Liabilities and Other

 

311,374


 

303,941

Total Liabilities

 

2,135,492


 

2,139,268




 
AptarGroup, Inc. Stockholders' Equity

 

1,957,901


 

1,850,389

Noncontrolling Interests in Subsidiaries

 

38,092


 

396

Total Equity

 

1,995,993


 

1,850,785




 
Total Liabilities and Equity

$

4,131,485


$

3,990,053

AptarGroup, Inc.
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)
($ In Thousands)






 

Three Months Ended

September 30, 2021

 

Consolidated Pharma Beauty +
Home		 Food +
Beverage		 Corporate &
Other		 Net Interest
Net Sales

$

825,442

 

 

313,225

 

 

374,088

 

 

138,129

 

 

-

 

 

-

 







 
Reported net income

$

46,894

 






Reported income taxes

 

19,340

 






Reported income before income taxes

 

66,234

 

 

75,611

 

 

14,443

 

 

12,027

 

 

(28,237

)

 

(7,610

)

Adjustments:





Restructuring initiatives

 

10,223

 

 

13

 

 

5,442

 

 

131

 

 

4,637

 


Net investment loss

 

9,021

 




 

9,021

 


Transaction costs related to acquisitions

 

1,793

 

 

1,793

 





Adjusted earnings before income taxes

 

87,271

 

 

77,417

 

 

19,885

 

 

12,158

 

 

(14,579

)

 

(7,610

)

Interest expense

 

8,011

 





 

8,011

 

Interest income

 

(401

)





 

(401

)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

94,881

 

 

77,417

 

 

19,885

 

 

12,158

 

 

(14,579

)

 

-

 

Depreciation and amortization

 

59,280

 

 

23,321

 

 

23,904

 

 

10,221

 

 

1,834

 

 

-

 

Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

154,161

 

$

100,738

 

$

43,789

 

$

22,379

 

$

(12,745

)

$

-

 







 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

18.7

%

 

32.2

%

 

11.7

%

 

16.2

%









 

Three Months Ended

September 30, 2020

 

Consolidated Pharma Beauty +
Home		 Food +
Beverage		 Corporate &
Other		 Net Interest
Net Sales

$

759,153

 

 

315,758

 

 

337,231

 

 

106,164

 

 

-

 

 

-

 







 
Reported net income

$

63,735

 






Reported income taxes

 

25,404

 






Reported income before income taxes

 

89,139

 

 

92,202

 

 

7,944

 

 

10,884

 

 

(13,289

)

 

(8,602

)

Adjustments:





Restructuring initiatives

 

3,415

 

 

300

 

 

3,144

 

 

(31

)

 

2

 


Transaction costs related to acquisitions

 

221

 

 

210

 

 

11

 




Adjusted earnings before income taxes

 

92,775

 

 

92,712

 

 

11,099

 

 

10,853

 

 

(13,287

)

 

(8,602

)

Interest expense

 

8,851

 





 

8,851

 

Interest income

 

(249

)





 

(249

)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

101,377

 

 

92,712

 

 

11,099

 

 

10,853

 

 

(13,287

)

 

-

 

Depreciation and amortization

 

55,179

 

 

19,724

 

 

23,634

 

 

9,498

 

 

2,323

 

 

-

 

Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

156,556

 

$

112,436

 

$

34,733

 

$

20,351

 

$

(10,964

)

$

-

 







 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

20.6

%

 

35.6

%

 

10.3

%

 

19.2

%



AptarGroup, Inc.
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income (Unaudited)
($ In Thousands)






 

Nine Months Ended

September 30, 2021

 

Consolidated Pharma Beauty +
Home		 Food +
Beverage		 Corporate &
Other		 Net Interest
Net Sales

$

2,413,228

 

 

952,400

 

 

1,081,280

 

 

379,548

 

 

-

 

 

-

 







 
Reported net income

$

186,107

 






Reported income taxes

 

55,309

 






Reported income before income taxes

 

241,416

 

 

245,087

 

 

36,253

 

 

31,728

 

 

(50,457

)

 

(21,195

)

Adjustments:





Restructuring initiatives

 

18,771

 

 

86

 

 

7,995

 

 

169

 

 

10,521

 


Net investment gain

 

(6,177

)




 

(6,177

)


Transaction costs related to acquisitions

 

4,227

 

 

4,227

 





Adjusted earnings before income taxes

 

258,237

 

 

249,400

 

 

44,248

 

 

31,897

 

 

(46,113

)

 

(21,195

)

Interest expense

 

22,601

 





 

22,601

 

Interest income

 

(1,406

)





 

(1,406

)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

279,432

 

 

249,400

 

 

44,248

 

 

31,897

 

 

(46,113

)

 

-

 

Depreciation and amortization

 

174,508

 

 

65,801

 

 

72,807

 

 

30,098

 

 

5,802

 

 

-

 

Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

453,940

 

$

315,201

 

$

117,055

 

$

61,995

 

$

(40,311

)

$

-

 







 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

18.8

%

 

33.1

%

 

10.8

%

 

16.3

%









 

Nine Months Ended

September 30, 2020

 

Consolidated Pharma Beauty +
Home		 Food +
Beverage		 Corporate &
Other		 Net Interest
Net Sales

$

2,180,011

 

 

914,213

 

 

961,577

 

 

304,221

 

 

-

 

 

-

 







 
Reported net income

$

160,845

 






Reported income taxes

 

66,998

 






Reported income before income taxes

 

227,843

 

 

267,523

 

 

2,297

 

 

25,365

 

 

(41,968

)

 

(25,374

)

Adjustments:





Restructuring initiatives

 

15,585

 

 

158

 

 

15,375

 

 

147

 

 

(95

)


Transaction costs related to acquisitions

 

4,812

 

 

210

 

 

4,602

 




Purchase accounting adjustments related to acquisitions and investments

 

4,642

 

 

1,421

 

 

3,221

 




Adjusted earnings before income taxes

 

252,882

 

 

269,312

 

 

25,495

 

 

25,512

 

 

(42,063

)

 

(25,374

)

Interest expense

 

25,973

 





 

25,973

 

Interest income

 

(599

)





 

(599

)

Adjusted earnings before net interest and taxes (Adjusted EBIT)

 

278,256

 

 

269,312

 

 

25,495

 

 

25,512

 

 

(42,063

)

 

-

 

Depreciation and amortization

 

162,414

 

 

56,232

 

 

70,159

 

 

28,031

 

 

7,992

 

 

-

 

Purchase accounting adjustments included in Depreciation and amortization above

 

(3,367

)

 

(667

)

 

(2,700

)




Adjusted earnings before net interest, taxes, depreciation and amortization (Adjusted EBITDA)

$

437,303

 

$

324,877

 

$

92,954

 

$

53,543

 

$

(34,071

)

$

-

 







 
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)

 

20.1

%

 

35.5

%

 

9.7

%

 

17.6

%



AptarGroup, Inc.
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
(In Thousands, Except Per Share Data)




 

Three Months Ended

Nine Months Ended


September 30,

September 30,


2021

2020

2021

2020





 
Income before Income Taxes

$

66,234

$

89,139

 

$

241,416

 

$

227,843

 





 
Adjustments:



Restructuring initiatives

 

10,223

 

3,415

 

 

18,771

 

 

15,585

 

Net investment loss (gain)

 

9,021

 

-

 

 

(6,177

)

 

-

 

Transaction costs related to acquisitions

 

1,793

 

221

 

 

4,227

 

 

4,812

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

-

 

 

-

 

 

4,642

 

Foreign currency effects (1)

 

800

 


 

11,096

 

Adjusted Earnings before Income Taxes

$

87,271

$

93,575

 

$

258,237

 

$

263,978

 





 




 
Provision for Income Taxes

$

19,340

$

25,404

 

$

55,309

 

$

66,998

 





 
Adjustments:



Restructuring initiatives

 

2,351

 

598

 

 

4,336

 

 

3,304

 

Net investment loss (gain)

 

2,075

 

-

 

 

(1,421

)

 

-

 

Transaction costs related to acquisitions

 

447

 

25

 

 

889

 

 

713

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

-

 

 

-

 

 

1,026

 

Foreign currency effects (1)

 

228

 


 

3,265

 

Adjusted Provision for Income Taxes

$

24,213

$

26,255

 

$

59,113

 

$

75,306

 





 




 
Net Income Attributable to Noncontrolling Interests

$

366

$

(19

)

$

381

 

$

(37

)





 
Net Income Attributable to AptarGroup, Inc.

$

47,260

$

63,716

 

$

186,488

 

$

160,808

 





 
Adjustments:



Restructuring initiatives

 

7,872

 

2,817

 

 

14,435

 

 

12,281

 

Net investment loss (gain)

 

6,946

 

-

 

 

(4,756

)

 

-

 

Transaction costs related to acquisitions

 

1,346

 

196

 

 

3,338

 

 

4,099

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

-

 

 

-

 

 

3,616

 

Foreign currency effects (1)

 

572

 


 

7,831

 

Adjusted Net Income Attributable to AptarGroup, Inc.

$

63,424

$

67,301

 

$

199,505

 

$

188,635

 





 
Average Number of Diluted Shares Outstanding

 

67,801

 

66,922

 

 

67,799

 

 

66,483

 





 
Net Income Attributable to AptarGroup, Inc. Per Diluted Share

$

0.70

$

0.95

 

$

2.75

 

$

2.42

 





 
Adjustments:



Restructuring initiatives

 

0.12

 

0.05

 

 

0.21

 

 

0.19

 

Net investment loss (gain)

 

0.10

 

-

 

 

(0.07

)

 

-

 

Transaction costs related to acquisitions

 

0.02

 

-

 

 

0.05

 

 

0.06

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

-

 

 

-

 

 

0.05

 

Foreign currency effects (1)

 

0.01

 


 

0.12

 

Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share

$

0.94

$

1.01

 

$

2.94

 

$

2.84

 





 
(1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings and earnings per share using current period foreign currency exchange rates.
AptarGroup, Inc.
Reconciliation of Free Cash Flow to Net Cash Provided by Operations (Unaudited)
(In Thousands)




 

Three Months Ended

Nine Months Ended


September 30,

September 30,


2021

2020

2021

2020





 
Net Cash Provided by Operations

$

83,792

$

153,741

$

259,373

$

381,427

Less:



Capital Expenditures

$

79,650

$

50,379

$

216,689

$

173,365

Free Cash Flow

$

4,142

$

103,362

$

42,684

$

208,062

AptarGroup, Inc.
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
(In Thousands, Except Per Share Data)


 

Three Months Ending

December 31,

Expected 2021

2020



 
Income before Income Taxes

$

73,312

 



 
Adjustments:

Restructuring initiatives

 

10,907

 

Net investment loss (gain)

 

-

 

Transaction costs related to acquisitions

 

-

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

Foreign currency effects (1)

 

(1,165

)

Adjusted Earnings before Income Taxes

$

83,054

 



 


 
Provision for Income Taxes

$

20,067

 



 
Adjustments:

Restructuring initiatives

 

2,206

 

Net investment loss (gain)

 

-

 

Transaction costs related to acquisitions

 

-

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

Foreign currency effects (1)

 

(319

)

Adjusted Provision for Income Taxes

$

21,954

 



 


 
Net Income Attributable to Noncontrolling Interests

$

(13

)



 
Net Income Attributable to AptarGroup, Inc.

$

53,232

 



 
Adjustments:

Restructuring initiatives

 

8,701

 

Net investment loss (gain)

 

-

 

Transaction costs related to acquisitions

 

-

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

Foreign currency effects (1)

 

(846

)

Adjusted Net Income Attributable to AptarGroup, Inc.

$

61,087

 



 
Average Number of Diluted Shares Outstanding

 

67,265

 



 
Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2)

$

0.79

 



 
Adjustments:

Restructuring initiatives

 

0.13

 

Net investment loss (gain)

 

-

 

Transaction costs related to acquisitions

 

-

 

Purchase accounting adjustments related to acquisitions and investments

 

-

 

Foreign currency effects (1)

 

(0.01

)

Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2) $0.88 - $0.96

$

0.91

 



 
(1) Foreign currency effects are approximations of the adjustment necessary to state the prior year earnings per share using foreign currency exchange rates as of September 30, 2021.
(2) AptarGroup’s expected earnings per share range for the fourth quarter of 2021, excluding any restructuring expenses, acquisition costs and changes in fair value of equity investments, is based on an effective tax rate range of 28% to 30%. This tax rate range compares to our fourth quarter of 2020 effective tax rate of 27% on reported and 26% on adjusted earnings per share.

 

Contacts

Investor Relations Contact:
Matt DellaMaria
matt.dellamaria@aptar.com
815-479-5530

Media Contact:
Katie Reardon
katie.reardon@aptar.com
815-479-5671

EX-101.SCH 3 atr-20211028.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 atr-20211028_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 atr-20211028_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 a52517971_htm.xml IDEA: XBRL DOCUMENT 0000896622 2021-10-28 2021-10-28 false 0000896622 8-K 2021-10-28 AptarGroup, Inc. DE 001-11846 36-3853103 265 Exchange Drive Suite 100 Crystal Lake IL 60014 815 477-0424 false false false false Common Stock, $.01 par value ATR NYSE false XML 7 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Oct. 28, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 28, 2021
Entity Registrant Name AptarGroup, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-11846
Entity Tax Identification Number 36-3853103
Entity Address, Address Line One 265 Exchange Drive
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Crystal Lake
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60014
City Area Code 815
Local Phone Number 477-0424
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000896622
Title of 12(b) Security Common Stock, $.01 par value
Trading Symbol ATR
Security Exchange Name NYSE
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://aptar.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a52517971.htm a52517971ex99_1.htm atr-20211028.xsd atr-20211028_lab.xml atr-20211028_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a52517971.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "a52517971.htm" ] }, "labelLink": { "local": [ "atr-20211028_lab.xml" ] }, "presentationLink": { "local": [ "atr-20211028_pre.xml" ] }, "schema": { "local": [ "atr-20211028.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "atr", "nsuri": "http://aptar.com/20211028", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "a52517971.htm", "contextRef": "c20211028to20211028", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://aptar.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "a52517971.htm", "contextRef": "c20211028to20211028", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://aptar.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001157523-21-001284-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-21-001284-xbrl.zip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

H[Q'G)](GL5QT431@I1+$9D.]"D_;P7=?/ FU M1@44BZ(0'^KJG80CEV*!"E-*"3SHE.T[*RWURM#*I5/ 65%/ZD&Q;-]9,=4[ M3T,NQ2)14;RU5OF?1'4ZDYB$7\,@F6!^2[VDP-S2J Z"A+" M"*]JD%E-;#2T*N.V+]Z)!% #JR6!C&GD8&M"Z>JD:*\[FT82&Z"P8CP,?W8Y(2#^],N#S+9NVV%RGE9O6 M;^L_$/H$?7JU"1(>7'%*(M=17D&#,R )9%J]:509-7#P%1=0X/0:G&Y+4,\2 M.%T!J('3DD!FU%L2;,$%3E< :N"T)) 9=1M6PA6(PKUKOG[N>DE,!\H/)F@- M22!C,W;0&N )R"N@P.EU9NP2[(L&3E< :N"T)) 9]29P&C@MKX "I]?@M 6K M90K,V,O(=(!D"^B3^GU*F2LO/3OL7G)'T64R[M,P0L$P35F+T%421S'Q^3<@ M?PWZ!'U2(QZ^@?PUR0J$P\9W63%LV+BM;2]8+AF&^S(AEPQVH+^LL;#>V M-U^7#$.@?X5$%^B_$>O?L('^0'_U1!?HOQ'K;S2WM\M5,@RK$KG??:Z=9 ,+ M"D96#!M-W-+4J\FIC((!_P+H+S&&_"1, Z870'_U1!?HOQ'KW]SB-EO), 3Z M5TAT@?X;L?Y6R]P7#*6)+BQ?8;?Q*E=/[CP>N/?\A'+^7]%G><=^=&Z^7ES6 M3J]ZO:L?(H[ D#[[WNW<"!!'GU%V1^_J.OWX +F#WP_.;Z^_7),[>AI2\K/# M_BE" WF,"AY7/"#'HS!_UNG5S7GWIO:] M^Z57^_?%>>];-B+?NA=?O_4^(8/_DMUTPR\MW)7]K&O:A^E=:?\7;CN[^G[% M6OD/3?PI!.43LB:_TKNSYS"4%AYRVCG[X^O-U9^7Y[7%YQT\.SC%5]-:9@[U M.&L<)L&_'V@I='\/C<; -*RATZ1-JS4T^G38:.IFH]UPVH:F#P^>$6(1,\JN MS0B2BW5&$)+$P6J,@B8@_B*K7P52.9])[2CPFO13= MCBCE9VQR6=U\E]_@FVRV^YO)LBQQE(QR9B* LNQIZDI ^C!B)J[&'2CFR/C! M0T@FR\*[:B[CO7.([ MM[?=WNTZR>^&# G].]\I5A8*.Q<4-6&K( JRV] S$HT0\^-1]Z_$O2<>GYJ5 M-#Y2A18EV)3H=I[ESYWHZ",*XQ MEW>,+OQ[&L7C$M6O2J>E;GGQK)*8F;H$]:@ET-XJC1G(^1KE8:RU5H0ES*3N M!3'Q4)%'CL6%G9H+J<9<%IY(!0IWV5M-"0X$E4#I2S4P(*W/^.UF:ZTZ 3OW MVSN.$R1\#9MKYW"7VXR!T*;C$;QJY"H-BF4ULKC<_!.T+TEHR*&:SC=E? M);7O=4@GQ!T(C_@J'O&SCI,P9 H9=:*(0E!;8@ZHA)ENM''3D. 8=0D4NDKC M!K*^CJP;N*%+Y(QO(KB]"Z,@U:C*P@2I0-&9EVYAS8852^F&!N2U6%X;+=Q> M[_PH"7SU8,+N?L3HVB-,&>>+C1.^G@CA:Q#T>4$W+";H#0F.00;%#/*Z@KSJ M[19N6FO-$'>NF+\&P>#!];Q]'#D0YP)0VJT&;JX7$03E"]):,B@MIGIM8ZWB MC#M7O6G,&F+5DLN[2IC9MHX;6RQ7I)+R5FG<0-;7D'7#Q,V6FDN7:61ZEZI? M^B-8)=ATIAID%M9-'5LM"8ZCED__2S]Z(/!OSU[![;:&-5NB!4NU2@7LG*12 MH"![P83O%YW3B^\7O8ON+>I M/;[-\ZK/[B;<&N]EKHP$7IA4>!B:C@THRB+?P("@+F]%;N)68ZVMR#M7O]/- MG=?D,=W/R:Z$"9W/;?_NDK[K,6A*VVND4C 0 JAOQZRI-;&N;^]@,Y54NTKC M!K*^WIYHJR%1G&B#B>WE6P:IAE86.D@%2EMK\7SAW:,B@6Z7:F! 6HL\D9:& M34/-I=SO ;L D1.0[&(]K-NX::]5<@CT,$AKR:#H6+,MW&ZKF4><2# M>8=X%D"!29&T'% ),U/7L=F$O4FJC1O(^CKU$DWPK2\D'%Z#8.G)^C MP&/N4O0O42PB?MQ'_H-2+(Q4M.TF;FNP>BW=T("\%LIKR^;%Y]5!AX'ON(J>>8AC2*(P8"NDWZ# B7E%@$6:4YM"QL4 DSLX4UF)XI-VP@ZFN( M>EO-C-4TO%:J4Z[2L (5UG+IVS;["]4K5!LYD/9U)P3-]?;J[US]2Q#/VCE# MI4!!]JC>DV6X:>777?D-TA$3E4_^C]7I7/\36%=;WL^_=SHT8B-%GE-W1 MN[I./SY [N#W@_/;ZR_7Y(Z>AI3\[+!_BF">?]%UYVNW=GK3[?Q1ZWSI==GC MB?= 'J."QQ6/V/$HS)]U>G5SWKVI?>]^Z=7^?7'>^Y:-P;?NQ==OO4_(X+]D M-]WP2PMW93_KFO9A>E?:_X7;SJZ^7[%6_D,3?PI!^82LR:_T[NPY#*6%AYQV MSO[X>G/UY^5Y;?%Y!\\.3O%5,03[92:NKO'GM%";J_\G2YG''_LGFW;1=MO#&^H$OL-<.K'= M 05#U!G\)XEBRGR[TXN>&?/DD&+OO\J&KPN">' MO[%NHMXH2"*&1,1ZZ&Z\AQ(X+(73&!.: $U0O FRSZHW E&9:K%U<-(;A92B M'\SO1R0<$Q6Z5M3Z4\HF>(_HOYX7/(2^L9F MJOW[$@2#EWMW2MG;R)VR/3P+PDD0,GJA?Y+QY/-+75UEAZ6T_4QGI6E*F\P* M7#3TEG@\S^Z%&7.%LR@9!K_QON\^8"P;+"W#QI9E* W.*KU]4C9I^^D'FU5, MJYI_J01,#80E!]'436P8VUNBE W%:M-9H7DE$01& N,51O$VM[@!UP%KJH-(G!U>UR5(+ZLUJ*KJH.K3F/76$8O1L+"FY-K1UF"Q&KC5MI3&9E<3 MC_7R,7=C-95/684FK-D$J2Q1:H503'Z5FN2ATL9Y*#:PEAW3V]BT-#GLV':@ MJ[29>P4R"90OM!!:6!T+W*?#(*2[LL=2&0]9#*Y4H#"1:32P8<+,L+QN0P9E M]4C4M'%#UX%$ZG4;>%(:*'SZ9F'+,H$GZG4;>%(:*)PG!M:,)O!$O6X#3TH# MA?'DT&BQV/HD\P+ MD+!8#DU0I0G;(?43U;-2)_2T%SW4EC:% M:=@P)#A58B_F@Q"DKQI[@#F*=1O(41HHHNB.LI@ /X ?VS8>$AS0"^S8O2 M*(7'UC3,IK*8J)5O6]T R*78O79/TU@G\H((0A]O&M,*@]+&F@$6^*W=AEB\ M"DVH)&%!BX$6 S]I*WY2+R1^1!QQ8)431'&$0NKQPP/XR53$^2MQ4^DLRWM2 M:0.A+&I))X#Q!$(5D 4 I .=0M;#>W=YB.K PY4K;' M0([20$EW!2L+2JG"PID,([JW=AOPX M:,)*3:BDS@!%"HKTW8I4'IHML*0 M"I2VA5LM"72",K-&R(!34E @ ZX %+78([DL "B0 0<$ 8) !AP0! @"&7"0 M 0?DV#8H-67QV,/EWG,Z":G#*^,'OHC,D7' OORWN*!TZ+7:C%<),[N-C98$ M*;%RA?B5B/:I)&9 S;=C9IC8E*&$&E!3=4D"S-9B7UNSJHH9L*\\20+,UCS^ M"6P?L _8MP/,=-PRP?0!^8!\.\!,@A!M58BW\PCN2DF7.,VXQ&CP4KQW*2'S MO+.=E,REH1\$2=^CV=@;=<.6/^_LMQV%[12&3+Z@9M6Z1LU5&!AZ8FXZDL3$%#^,+$*U%,X5+SS8B.E-P%J"T(3 MUFY"RG1YZ;RT6)-IK^6R&NR#C^B&3H*07^&'PM\2CT;O7-IYH\%1X&AWJIOKQ:!9 BNZU)\D!P@E=>!@,/OQ]!DOO>^(%A5#DLN8D#3#9A:'4PM MT!1H*CF&>@.LZ19I6JD0A(JG7:L)&S0!FK"M)L@>2-P(1 4&R*$\_7Q#%FAN M$/36P4EO%%**?@1^/(I0UQ_0 >#[]I#.:]LOGH7_EDYB.N[3$)D:1H9F: #_ M)L5[+U1&@5;=F7B?G 6^N(W$+Z@2B?KPYJ7-ZQ$)QT2%KA6U_I22)'Y$__6\ MX"'T[?4#BZ3MWY<@&+S?7^KJ53RBH:K] MY$NL^2E:,BOPD^E:\/''_HG;.*"=9D2_31I0+1U&W-A2!LR[3PIB,6HV%A3(@"48IKH&FZU@"<*=AMX4AHHC">' MNHF-UGY.7ECWCY3N.%"E-% X55JXL:=!O;2F]ICZMJ+&QK%8>+$2<@^8MJ=J7D2N_<\7"^S2@8;7AHH)K;T MTL^DVKGMAA ]D&<3Y-$T91%1BSJ2"P* 4FA:=&M[FXV!'PJ) H!2 ,KA%HMG MR,J.TD_ZE%P&@!@%H&SO/ %9:;&;+-OJQCUZ(?$CXG#A8^^)X@B%U..E<%$< M(.+\E;BI9)85!U$I'5X6E:029H8A@2FOUL:!4D(L*LD8\'(-7NH2!&B EZJ+ M$6"VSO%]5<5+=2=_/_=1R=]"29)"V"2)DM!G'T;%&[UDGH!76_]+!4K;P,TF M+!V7TVU8.JX@>W0(="K6;2!(::#H.M;:;65! 8( 0;9,$ VW;%-94( @0) M MYU>(;5Q-95&!' L@Q_;((39N*0M*J=S8>6 N/W\3T5\3ZD>OG9E:28$%%A> MTF(NH 3K+(JY@+"=$)JP4A,JJ3- D8(B?;6[I45>98TG\09KQA@ZG M7^B>7O2.Y)X+5%MA2 6*KNG8;.[? A.DP %]( 5.+?9(+@L "J3 4& () " M!P0!@D *'*3 3FV#4I-63SV<+WWG$Y"ZO#JQ8$O0G-D'+ O_RTN*!U[K3;C M5<+,MK'>E&"^)5>,7XEHGTIB!M1<8Z;7QDU#@F*R0$W5)0DP6Z.,EHD;)K / MV ?LVP%F;6RU6U6%#,A7GB !9FN8/FP:$JPP /E4%R3 3,D(;56(M_, [DI) MESC-N,1H\%*X=RDA\[RSG93,I:$?!$G?H]G8&W7#EC_M[+<=1>T4ADRW&]BV M&U4&3BVKOP(R*F>& D772(LSL&4"156BJ.0B!2Q\,V2FA9MFZ3-C(*$,R ) M)8',T+!9?MT*(*$,R ))8'L4-=PNU'Z\J@*+"P]#U=]:0("RA\F5H%Z"H>* M=UYLI/0F0&U!:,+:34B9+B^=EQ9K,NVU7%:#?? 1W=!)$/(KES1&M\2CT3N7 M=MYH<-38&AH]>U%E"5#<%V7XH/D *F\#@0OL)N(WV/ M/KGS>.#>G[!/^7]%G^6=^-&Y^7IQ63N]ZO6N?GQBMH=-!=#9]V[G1G1H]!EE M=_2NKM./#Y [^/W@_/;ZRS6YHZM/M_%'K?.EU MV>.)]T >HX+'%4OD\2C,GW5Z=7/>O:E][W[IU?Y]<=[[EHGDM^[%UV^]3\C@ MOV0WW?!+"W=E/^N:]F%Z5]K_A=O.KKY?L5;^0Q-_"D'YA*S)K_3N[#D,I86' MG';._OAZ<_7GY7EM\7D'SPY.\54QRLBA'A=#A\G7[P=:"MW?CDFI;0^'=MML M6,.!W6]K?9UI")+$P6]R_:28A M12/T]A#:*WK/H3SK>4.*;X[!>IL3\J0SB4GX-0R2"487OE,__M@_V720<+<] MO*%.X#NNEZ6)!T.T$%$4>>/+,<8X$+'%B_1$^\,_?9(,7/;Y4=7@<4\.?V/= M1+U1D$0,"1Y)=3?>0UCT@29 $[;3!-G7=38"49EJL75P0M]>/SY.VOY]"8+!R[T[ MI>QMY$[9'IX%X20(&;W0/\EX\OFEKE[%(QJJVL]T4IKN@I99@9],,W->G#!O M]L52Q<49!K_QON^^-H%LL!C8XO6FC9;2\$BZXV2SJ@ER9$KTTJ4"L6TSFFK: MWJ!8;3I++FP XB86XK'6TK'1 LX"9TL0-P!Q$ZFHS3:VK>U5[90-16 L,%9M M$+>WB50V_("KP%6U002NPN[OITW8T<*KJUH*V1$+TK"XIN3JT=9@T5L-K&M-I<'9U:QDRV\:FUI;#CE7E=(\2S=PKD$F@?*&%T,+J6.#LE)P=V6.IC(I:5C2V_(85(5LYFEG$XNE< BYYCD8VU%@18%.PV$*4T4!A1S 8V M;!-XHEZW@2>E@<)YHN,F[(51L=O D]) 83PYM#5LV?OI>+'N'RG=<:!*::!P MJA@ZUMNVTA*S"ZKL/+"7EB$;4S^./LF\!@GKY= $59JP'5(_43TK=4)/>W%# MHSA,G#@)V4=,O3,]3V+WGH?L95;)8,1+ T5OX6:S]!,[=VZ\(4P/[-D **W2 M3WW?4^9(+@< 2@$H3=QNV\IB OP ?FS9]6JTE44$V 'LV#([-&P;,#%Y:[46'% QI8%RV,!ZLZDL*.NJF"/),_I5C?]*TX1* MDA4T&&BPG6FPZOI'O9#X$7'$@55.$,41"JG'3P_@)U,1YZ_$326SK!4CE38/ MRJ*25,+,PH8A@<*JUD;+4E:C5)(R8"8P$\G 3)EWET(+]Z&%DJ0:,H>2DM!G M'T;%6XAEGJ=4VTA)!8IAM[!A2F"'%#,TD)"DF*!LB3Y6>ZNGJ0!]%!(& *5H MFL/F.5L\" $(HI L "@%H)@Z;K7! 5.LVT"0TD YM!I8UTUE4=G!JELEY0#( M442.=$>PLJB42HZ=Q^;R$YX1_36A?O3:J=R5E%B@<5$ SE* Z6F+!Y[N.A[3BL8>.6#&E:0$W5)0DP6^.H (.Q3X) M"[!/=4D"S-8(1379 ,R5CM%4AWLY#N"OE M7>(TZ1*CP4L!WZ6@K'BG=> MB=:SMO M-#AJ[F79\EQG+S#46_7M)5E)AN"Z+L4'R0%2>2$(.+R!E2&SOKU9N&0(5I7# MDHL8T'0#IE8#4PLT!9I*CJ'>J&^O=H1D".Z II4*0:AX]+6:L$$3H G;:H+L M@<2-0%1@@!S*\\\W9('F!D%O'9QT3GM>T7SZ)_ M2R\!#Z]OJY1=+V[TL0#%[NW2EE;R-WRO;P+ @G0M,1R]&PM*;D MVM'68&%2C%N6K30XNYIY0 T :(+\39#*%*5F*"W_7*(Q4JD:.E207\N0-1JX MW6[)8<>J4DV^1#/W"F02*%]H(;2P.A8X.Y5A1_98*N,AB\&5"A2>=6DTV=30 ME,.D*F8S2SD.5RJ! 18]PZ)&$]L&L$C!;@-12@-%)/D;[2;01+UN TU* X73 MQ,9F ^+U"G8;>%(:*(PGAY:.VPU) H(E$X5U_TCIC@-52@.%4X7;E*:EM,3L M@BH[C^NEA;7'U(^C3S(O0<)R.31!E29LA]1/5,]*G=#37MS0* X3)TY"]A%3 M[TS/D]B]YQ%[F54R&/'20-%M;+=*/Q]NY\8;HO3 GHVP9WMUJH$Z"@D"@%)L M6\PFV!;%N@T$*0T4W=I>"0U@AT*" * 4@')8_KG5.V?'.X[#A=C'8NRC%Q(_ M(@Z7//:>*(Y02#U>%!?% 2+.7XF;BB7$0MXTTA4&Q<(MW5 6$[4,,H1"*D8> M0]>4140MZD@N" !*H6EI:&!:WMKM?5]1E* )$CKVUTGHC$A$F1/O!(D?\Z5- M,LMG>,[-1\3G>YCN:7:?TCLZJZVZ5<*,:79+ LU>K8W#[YI3/(0IH6SN1,EH<\^ MC(JK/<@1',34.*R:*"T>+RLJ0=^215E(.@!Q%Y$BK M-RB+2JGDV'EL[H*?2$*C&-%?$^I'5.ZQ 1J7!@IC<;NY?R9.B>+D$BQ40!/> MV81**@W0I*!)WZ])Y7&*\E/*%,XJJ#;15<+LT&ZWJXJ8,CM3X1@8:&&)+92; MM6 ;9,$,;$-5 FK/)KNEI]YFCB7?-232WM#A] O=TXO>D=QS@6HK#*E ,9HM M;-@-95%1:Q46TN"J1A](@U.QV\"0TD"!-#@5NPT$*0T42(-3L=M D-) @30X MU7H,Y"@-E)JR>.SA@N\YG834X:>8!+Z(S9%QP+[\M[@@]V@!I4L#16\8V-+W M+[,50G) GPV 8C>P8<)\2K%N T%* Z6I8=V68!D8"+)[60!0BB)R+:R9$M1_ M H+L7A8 E"(+@MMM\+ 4ZS;PHS10("BW>K=W'I1[K2*WZSM>,J"\_#9Z,8"' M2#^XAUT<\NH(E3 [-+'9D." O0KDZI88'51)PH"5:["R 9S<.2?5%B&@W3JU M7G!3D^"$KLH03_X=;=#":M;BGM^>A-.]21@-7IQ6+6Y=.N]L9_/2TC ,@J3O MT6P]7I7/SXA76,S 73VO=NY$1T:?4;9';VKZ_3C ^0.?C\XO[W^ MW9QW;VK?NU]ZM7]?G/>^92+YK7OQ]5OO$S+X+]E--_S2PEW9S[JF?9C>E?9_ MX;:SJ^]7K)7_T,2?0E ^(6OR*[T[>PY#:>$AIYVS/[[>7/UY>5Y;?-[!LX-3 M?%6,,G*HQ\708?+U^X&60O>WU=:&S:'I#+6&9EEMH]TRF_:PWVP9?GL$[16]YU">]+PAQ3?' M8-W@A#SI3&(2?@V#9(+1A>_4CS_V3S8=(]QM#V^H$_B.ZV59XL$0S0**>8[Y M-0W1N>LE_.+MB(04'?[IDV3@L@M'58/$/3F\\%%O%"01\0<11MU?#IW$ H2T M\^=/ MO5%(*?K!/(M1A+H^+Q>QDN_'[UJ$&9.G#<\^BON7IWOTP6E!E""5$H'Y=I260W]#E/\ZLV7%6RR_%/\DPO?"<8T+\^1_=;C=3E> M#)CN-A HU=HI _$WCE4IZZ>5AK'!CVZPMHJELMAL5\24A:75QKK95AH;23>] M[HW6 >6]$1@-2\>6WM@K,"6EKK(R!$:NF%I&$[!'Z6! MHK=PL_QB:$ 0&64!0"DBB(WM%EB0U;LMX83B4IQ9P2808G*,O""*T.$=;0GG&U^"D+*;D).$(?6=1T2'0^JPB<:A_EI" MU*;V#+U2?>\=FVDV)6 KU@>4@I.R*"J5,&MI6E4!VY43L*E];* <0#GL>.U6 MQUI[>^?I[)U^V/GNZ*='31362U/\\'$XXEX2R%I-;)2_JTI]W$#4WKYQP<1V ML_3]267BIE9,2WV) A*^/87+;F'#+#U-!5@H S+ 0DD@,QHF;C=;509N#Z=N M4(1MFTU8;R%!WC9)7Z9-L1KX<#@"-%GAPQ&NP^#>C?BFK6$0PN$(,A;UW1L8 M]38V+4WI&L"*BIBRL!@VMC2US].0-&ZP-UH'E/=&8+1M;&K;/:9$-BPE9:ZR M(@0VKA"61@.WVRVEL8&HW.I#!5&YRC5!^C@ '(T 38"C$2KG/("C6;0(BDU; MW7HR("BE@6*W2U\I5]CAEJ+;P([20+&P:4JP 0#XL7M1 % *0#&QJ5G*8E*5 M@ VX.K=EG"^ <&E M\FB*5TJ%JKR20&98V"A_249]W$#4WBYJ#6S8EJDW#GTS:HN;;-)L!)"'FS%)+F IS@) 3%CQ50 ML,GR\@"?)TX#MU^$A-NG>, 70;LNA^'@>?Q7,L+#A.-8C@B09;:OGL# MH]EH ) @C]+ >*A#R?=5)E4,JJ.] @J(*S>,9DO?*R E#4G*!A/05FX8#\WF M7@&Y"WLKP614K?D]!'Z@R=4,_'0F,0F_AD$RP?R6.H*(#UC\2F;BI[U<<$J:/P-P*P*BW&MAJ;?#H M4"#\6TOMFS"C $%905#:ZHH)S"F '=L%Q<2F*4&M?^#'[D4!0"D Q<):&\[7 M7;W;$LXMX 114 D0:@ A 2&1U&9(T6W@1FF@ #<4ZS9PHS103-S0(5ZU>K6@'&9-W#(ER/FNBGK8^=[H MZ0FB;Z@NI_R10W"ZE220-4QL&1;@!J*V?5%K8E,KW7)5^R U59 !$DH"F=YN M8UN#@WV!A<#"';*PU<*-\K>V5YN%.Y_)J59T':KQ0Y,5KL;?8;>3.XHNDW&? MAB@8HG/72W@DY79$0AJAJR2.8N+S[T(U?BD"LOL!(B]\WL0M;;_.S0*!E!9$ M+I -W#:,O1)(2>>!LL$$O)46Q-20--MPO:;@8#X(0T,K&"P[BV0B,6KT)QS&"0,H#HU9OVWN% M)$PE@;<5@-&H-X&WP-OR! YXNR'>6K#D B&@XB; "7>5:X+T(10XAA&: ,

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end